Patients’ ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial
Allergy2015Vol. 70(7), pp. 855–863
Citations Over TimeTop 10% of 2015 papers
Thisanayagam Umasunthar, Annabella Procktor, Matthew Hodes, Jared G. Smith, Claudia Gore, Helen Cox, Tom Marrs, Heather Hanna, Katie M. Phillips, Camila Pinto, Paul Turner, John O. Warner, Robert Boyle
Abstract
AAI device design is a major determinant of successful adrenaline administration. Success rates were low with several devices, but were high using the audio-prompt device Auvi-Q.
Related Papers
- → Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities(2018)117 cited
- → Epinephrine in anaphylaxis(2015)23 cited
- → Epinephrine (Adrenaline) in Anaphylaxis(2010)19 cited
- → Pediatrician perspectives on symptom presentation and treatment of acute allergic reactions(2020)10 cited
- → 363: COMPARING EPINEPHRINE 0.3 MG AND 0.5 MG AS AN INITIAL DOSE IN COMPLETE RESOLUTION OF ANAPHYLAXIS(2022)